tiprankstipranks
Trending News
More News >

Adaptive Biotechnologies price target raised to $13 from $11 at Piper Sandler

Piper Sandler raised the firm’s price target on Adaptive Biotechnologies (ADPT) to $13 from $11 and keeps an Overweight rating on the shares. The firm updated the company’s model post the earnings report.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue